KENNEY CHRISTOPHER JOHN — SEC insider filings

SEC reporting owner CIK 1880129. 11 insider filings on record with FilingPulse; latest filed 2026-08-31.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2021-08-25 to 2026-08-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Xenon Pharmaceuticals Inc. (XENE)Chief Medical Officer111 leg · 700 sh · $20,1675 legs · 11,949 sh · $694,76313

Insider filings — KENNEY CHRISTOPHER JOHN

FiledFormIssuerReported transactionsSource
2026-08-314Xenon Pharmaceuticals Inc. (XENE)Sale (S): 6,368 @ $60.17 · Sale (S): 700 @ $60.98EDGAR
2026-03-134Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 3,750 · Sale (S): 1,410 @ $55.23 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2026-03-114Xenon Pharmaceuticals Inc. (XENE)Option exercise (M): 7,500 · Sale (S): 2,771 @ $60.11 · Grant/award (A): 7,500 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2026-01-094Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-03-134Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-03-124Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-03-244Xenon Pharmaceuticals Inc. (XENE)Sale (S): 700 @ $35.01EDGAR
2023-03-144Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 120,000 (derivative) @ $0EDGAR
2022-03-144Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-214Xenon Pharmaceuticals Inc. (XENE)Purchase (P): 700 @ $28.81EDGAR
2021-08-254Xenon Pharmaceuticals Inc. (XENE)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1880129 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs